51 related articles for article (PubMed ID: 1529807)
1. Captopril inhibits the fluorescence development associated with glycation of proteins.
Le Guen CA; Bain S; Barnett AH; Lunec J
Agents Actions; 1992 Jul; 36(3-4):264-70. PubMed ID: 1529807
[TBL] [Abstract][Full Text] [Related]
2. Does captopril attenuate reperfusion-induced myocardial dysfunction by scavenging free radicals?
Westlin W; Mullane K
Circulation; 1988 Jun; 77(6 Pt 2):I30-9. PubMed ID: 2836109
[TBL] [Abstract][Full Text] [Related]
3. Effect of .OH scavenging action by non-SH-containing angiotensin converting enzyme inhibitor imidaprilat using microdialysis.
Obata T; Yamanaka Y
J Physiol Paris; 1998 Feb; 92(1):1-4. PubMed ID: 9638590
[TBL] [Abstract][Full Text] [Related]
4. [Angiotensin-converting enzyme inhibitors as neutralizers of hydroxyl radical].
Mira ML; Silva MM; Queirós MJ; Manso C
Rev Port Cardiol; 1992 May; 11(5):425-30. PubMed ID: 1325814
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the free radical scavenging activity of captopril versus enalapril: a three month in vivo study in hypertensive diabetic patients.
Bain SC; Le Guen CA; Lunec J; Barnett AH
J Hum Hypertens; 1991 Dec; 5(6):511-5. PubMed ID: 1791611
[TBL] [Abstract][Full Text] [Related]
6. Captopril inhibits the oxidative modification of apolipoprotein B-100 caused by myeloperoxydase in a comparative in vitro assay of angiotensin converting enzyme inhibitors.
Van Antwerpen P; Legssyer I; Zouaoui Boudjeltia K; Babar S; Moreau P; Moguilevsky N; Vanhaeverbeek M; Ducobu J; Nève J
Eur J Pharmacol; 2006 May; 537(1-3):31-6. PubMed ID: 16631159
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human platelet aggregation by endothelium-derived relaxing factor, sodium nitroprusside or iloprost is potentiated by captopril and reduced thiols.
Mollace V; Salvemini D; Sessa WC; Vane JR
J Pharmacol Exp Ther; 1991 Sep; 258(3):820-3. PubMed ID: 1716310
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological evidence that captopril possesses an endothelium-mediated component of vasodilation: effect of sulfhydryl groups on endothelium-derived relaxing factor.
Goldschmidt JE; Tallarida RJ
J Pharmacol Exp Ther; 1991 Jun; 257(3):1136-45. PubMed ID: 1646324
[TBL] [Abstract][Full Text] [Related]
9. Free radical scavenging: a potentially beneficial action of thiol-containing angiotensin converting enzyme inhibitors.
Chopra M; McMurray J; Stewart J; Dargie HJ; Smith WE
Biochem Soc Trans; 1990 Dec; 18(6):1184-5. PubMed ID: 2088853
[TBL] [Abstract][Full Text] [Related]
10. Different effects of thiol and nonthiol ace inhibitors on copper-induced lipid and protein oxidative modification.
Fernandes AC; Filipe PM; Freitas JP; Manso CF
Free Radic Biol Med; 1996; 20(4):507-14. PubMed ID: 8904291
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of ACE inhibitors on vascular endothelial dysfunction induced by exogenous advanced oxidation protein products in rats.
Chen SX; Song T; Zhou SH; Liu YH; Wu SJ; Liu LY
Eur J Pharmacol; 2008 Apr; 584(2-3):368-75. PubMed ID: 18334254
[TBL] [Abstract][Full Text] [Related]
13. Effect of captopril and enalapril medication on the serum ACE test for sarcoidosis.
Lieberman J; Zakria F
Sarcoidosis; 1989 Sep; 6(2):118-23. PubMed ID: 2557660
[TBL] [Abstract][Full Text] [Related]
14. Impairment of endothelium-dependent relaxation of rat aortas by homocysteine thiolactone and attenuation by captopril.
Liu YH; You Y; Song T; Wu SJ; Liu LY
J Cardiovasc Pharmacol; 2007 Aug; 50(2):155-61. PubMed ID: 17703131
[TBL] [Abstract][Full Text] [Related]
15. Captopril ameliorates the decreased Na+,K(+)-ATPase activity in the retina of streptozotocin-induced diabetic rats.
Ottlecz A; Bensaoula T
Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1633-41. PubMed ID: 8675407
[TBL] [Abstract][Full Text] [Related]
16. Sulfhydryl group in angiotensin converting enzyme inhibitors and superoxide radical formation.
Mehta JL; Nicolini FA; Lawson DL
J Cardiovasc Pharmacol; 1990 Nov; 16(5):847-9. PubMed ID: 1703610
[TBL] [Abstract][Full Text] [Related]
17. Captopril inhibits capillary degeneration in the early stages of diabetic retinopathy.
Zhang JZ; Xi X; Gao L; Kern TS
Curr Eye Res; 2007 Oct; 32(10):883-9. PubMed ID: 17963108
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin-converting enzyme inhibition and free-radical scavenging properties of cationic peptides derived from soybean protein hydrolysates.
Farzamirad V; Aluko RE
Int J Food Sci Nutr; 2008 Aug; 59(5):428-37. PubMed ID: 18636366
[TBL] [Abstract][Full Text] [Related]
19. Should the use of short acting angiotensin-converting enzyme inhibitors be abandoned?
Erman A; Boner G; van Dijk DJ
J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):365-8. PubMed ID: 11967825
[TBL] [Abstract][Full Text] [Related]
20. Interactions between carnosine and captopril on free radical scavenging activity and angiotensin-converting enzyme activity in vitro.
Nakagawa K; Ueno A; Nishikawa Y
Yakugaku Zasshi; 2006 Jan; 126(1):37-42. PubMed ID: 16394648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
